Ibogaine HCl (ATAI Life Sciences/DemeRx)

N/A

Report date: 2025/05/06 16:57:09

Base Information

Drug NameIbogaine HCl (ATAI Life Sciences/DemeRx)
Drug Alias Nameibogaine HCl (ATAI Life Sciences/DemeRx)Ibogaine Hydrochloride (ATAI Life Sciences/DemeRx)oral formulation of ibogaine (ATAI Life Sciences/DemeRx)Ibogaine (ATAI Life Sciences/DemeRx)DMX-1002 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonistsOpioid receptors antagonistsExcitatory amino acids antagonists
TargetsGlutamate [NMDA] receptorOpioid receptorsExcitatory amino acids
Therapy Area/IndicationsSubstance Withdrawal Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAtai Life Sciences NVDemerx
China Registration ClassN/A

Develop Information

Active CompaniesAtai Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSubstance Withdrawal Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A